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This study involved 1,564 black or white patients diagnosed in 1992 to 1997 with non-small-cell
lung cancer, reported to thepopulation-based Connecticut TumorRegistry, who were linked with a
statewide hospital discharge database that provided information on comorbid conditions. While
only 11.4 percent ofpatients did not receive surgical treatment (lung resection), this proportion
increased with rising age andwas higheramongpatients who resided in a census tract in the high-
est poverty-rate quintile, were black, not married and had one or more selected comorbid condi-
tions. These associationspersisted in logistic regression models that includedall ofthe variables as
predictors ofsurgery. Studies are needed to explain these disparities.
Non-small-cell lung cancer
(NSCLC)b comprises 75 to 80 percent of
all lung cancers, and about 30 percent of
patients are candidates for curative surgi-
cal resection [1, 2]. Using data from three
population-based registries in the National
Cancer Institute's Surveillance,
Epidemiology and End Results (SEER)
Program, surgical treatment among black
or white early-stage NSCLC patients diag-
nosed in 1978 to 1982 (age less than 75
years) was positively associated with
median family income of census tract of
residence [3]. In another SEER study,
surgery rates among elderly patients were
lower in the lowest quartile (vs. the high-
est three quartiles) of median income of
ZIP code of residence, and for black than
white patients (independent of various
characteristics) [4]. In the latter study,
comorbidity was examined only for the
small subsample with a hospitalization in
the previous year [4], raising concerns
about the degree of control for confound-
ing due to comorbidity [5]. However, ver-
sions of the Charlson comorbidity index
[6] adapted for use with administrative
databases include most conditions coded
for the index hospital discharge as well as
a prior discharge [7, 8].
This study used a population-based
statewide cancer registry and a statewide
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inpatient hospital discharge database
(HDD) to examine socioeconomic status
(SES), age and comorbidity in relation to
surgical resection among early-stage
NSCLC patients of any age at diagnosis.
HDDs are being used increasingly in med-
ical outcome studies [9], and analyses of
inpatient hospital admissions canbe useful
as a first step [10, 11] in adjusting for
comorbidity.
MATERIALS AND METHODS
In Connecticut, a statewide HDD,
maintained by the Office of Health Care
Access, has covered (since 1992) all acute-
care hospitals in Connecticut; for a given
hospital, the medical record number is
unique for each patient. The latest HDD
file available included complete data for
admissions from January, 1992, through
August, 1997. The population-based
Connecticut Tumor Registry (CTR), locat-
ed in the Connecticut Department of
Public Health since its inception in 1941
[12], has been part of the SEER Program
since its inception in 1973 [13]. SEERreg-
istries have high rates of completeness of
reporting of data from hospitals [14]. In
Connecticut, state public-health legislation
requires reporting of cancers to the CTR
by all licensed hospitals and clinical labo-
ratories in the state, and the CTR has reci-
procal reporting agreements with cancer
registries in all adjacent states and other
states (including Connecticut residents
diagnosed in Florida).
The original CTR data file included
9,044 Connecticut residents diagnosed
fromJanuary, 1992, throughAugust, 1997,
with invasive NSCLC, International Clas-
sification of Diseases for Oncology (ICD-
0-2) site codes 18.0-20.9, and morpholo-
gy codes 8010-8040, 8050-8076, 8140,
8250-8260, 8310, 8320, 8323, 8550-8573,
or 8980-8981, as the only or first-diag-
nosed reportable cancer, after excluding a
small number ascertained solely by autop-
sy or death certificate.
Almost all patients (i.e., 8,994 or 99.4
percent of 9,044) were coded as white or
black race; the 50 patients of other or
unknown race were excluded from further
analysis. While Hispanic ethnicity is
coded in the CTR as a separate data item,
the number of Hispanic patients is small
(i.e., about 2.5 percent of NSCL patients)
and the reporting of Hispanic ethnicity by
hospitals is of uncertain validity, so that
separate analyses of patients of Hispanic
ethnicity were not done.
Of the 8,994 black or white patients,
the 319 forwhom census tract ofresidence
at the time of diagnosis was not coded in
the CTR were excluded from further
analysis. Because cancer registries do not
include indicators ofSES reported directly
from patients, an ecologic indicator(s) of
patient SES is assigned to each patient
[15]. In this study the ecologic or geopo-
litical unit was the census tract. The eco-
logic indicator ofpatient SES was the cen-
sus tract's poverty rate from the 1990
Census, which is the proportion of the
entire population with incomes below the
federal poverty threshold. Poverty rate,
rather than household income or other
indicators for census tracts, was used
because household size is taken into
account in defining poverty status.
Of the remaining 8,675 patients, only
those with early-stage cancer, for whom
surgery is recommended, were appropriate
for analysis of surgery. SEER site-specific
surgery codes were used to define early
stages (similar to American Joint
Commission on Cancer orAJCC): I (TI or
T2, no lymph node involvement) and II
(Ti or T2 with involvement of intrapul-
monary, hilar, or peribronchial lymph
nodes; or T3 with no lymph node involve-
ment). Of the 1,822 early-stage black or
white patients (19.3 percent of all 8,675),
1,627 (89.3 percent) had at least one hos-
pital admission in the CTR database thatPolednak: Disparities in lung cancersurgery 311
linked (i.e., on hospital, hospital medical
record number, and gender) with the
HDD, which was necessary forassessment
of comorbidity. Some non-linkage was
anticipated, due to the absence of an inpa-
tient hospital admission for some patients,
an out-of-state hospital (notcoveredby the
HDD) and/or erroneous or missing med-
ical record numbers.
Ofthe 1,627 patients, 63 were exclud-
ed because the first HDD admission more
than two months after diagnosis of
NSCLC, and comorbidity would be uncer-
tain, or survival after diagnosis was less
than two months, so that there was limited
opportunity to schedule and receive surgi-
cal resection. Of the 1,564 remaining
patients, 90 percent had a first admission
within two months before the diagnosis of
NSCLC.
Surgical resection was defined by
using SEER site-specific surgery codes 20
to 70 (i.e., partial or wedge resection,
lobectomy or pneumonectomy). This defi-
nition does not include local surgical exci-
sion or destruction of lesion (SEER code
10), which is not considered standard
(non-palliative) therapy [2].
The principal diagnosis and up to nine
other diagnoses are coded in the HDD,
using the International Classification of
Diseases, Ninth Revision, Clinical
Modification (ICD-9-CM). For the first
admission that linked between the two
databases, all codes were searched for
clinically important comorbid conditions,
or those conditions having some effect on
short-term survival, derived from the
Charlson comorbidity index [6] adapted
for administrative databases that use ICD-
9-CM codes [7, 8]. After combining sub-
groups such as mild and moderate or
severe liver disease, the conditions (and
their ICD-9-CM codes) selected were:
cancer other than lung cancer (codes 140-
161, 163-200-208); diabetes (250); periph-
eral vascular disease (441, 443.9, 785.4);
myocardial infarction (410, 412); cere-
brovascular (430-8); congestive heart fail-
ure and related conditions (428, 402.0-
402.1, 425); hemiplegia, paraplegia (342,
344.1); chronic pulmonary (490-6, 500-5,
506.4); renal disease (582-583, 585, 586,
588); rheumatologic (710, 714, 725);
ulcer (531-4); chronic liver (571-2);
dementia (290); and HIV (042).
"Metastatic solid tumor" (codes 196-199)
[7, 8] was excluded as a comorbid condi-
tion in this study of cancer patients.
In multiple logistic regression models
[16], the dependent variable was non-
receipt vs. receipt of surgical resection.
The independent variables were categori-
cal or "dummy" variables that included
age at diagnosis (less than 55, 55 to 69, 60
to 64, 65 to 69, 70 to 74, 75 to 79, and 80
or more years), sex (female vs. male) stage
(I orII), the SES indicator (quintiles), mar-
ital status (married or other), race (black
vs. white), andnumber ofcomorbid condi-
tions (0, 1, or 2 or more). Using the fre-
quency distribution ofcensus-tract poverty
rates (from lowest to highest), patients
were divided into five groups with approx-
imately equal sample sizes (i.e., quintiles)
for the SES variable.
All odds ratios (ORs) tabulated were
adjusted ORs from the full model, with all
of the variables included. Confidence lim-
its (95 percent CLs) on adjusted odds
ratios or ORs were based on the Normal
approximation. Interactions were tested by
the Wald statistic (with chi-square distrib-
ution) [16].
RESULTS
Of the 1,564 early-stage (I or II)
patients, 179 (11.4 percent) did not have
surgical resection. This figure was higher
forpatients in the highest-poverty quintile,
older patients, black (vs. white) patients,
patients with one or 2+ (vs. 0) comorbid
conditions, and for non-married (vs. mar-
ried) patients, but differed little by gender
or stage (Table 1). In a multiple logistic312 Polednak: Disparities in lung cancer surgery
Table 1. Adjusted odds ratios from a multiple logistic regression model for non-
receipt of surgical resection among 1,564 early-stage NSCLC patients (Connecticut
residents) diagnosed in 1992 to 1997.
Total No resection Adjusted ORb
Characteristic no. (%)a (95% CL)a
Comorbid conditions:c
0 984 8.8 Referent group
1 436 13.8 1.51 (1.05, 2.19)*
2+ 144 22.2 2.59 (1.60, 4.18)*
Age:
<55 181 1.7 Referent group
55-59 145 7.6 4.55 (1.23, 16.81)*
60-64 224 8.9 6.13 (1.77, 21.18)*
65-69 301 8.3 5.36 (1.58,18.20)
70-74 322 10.6 6.68 (2.00, 22.35)*
75-79 261 15.3 10.06 (3.02, 33.54)*
80+ 130 35.4 29.05 (8.65, 97.62)*
Marital status:
Married 971 8.7 Referent group
Other 593 16.0 1.58 (1.10, 2.26)*
Poverty rate of census tract:
0.0-1.8% 340 8.5 Referent group
1.9-2.9% 321 11.2 1.27 (0.74, 2.18)
3.0-4.2% 278 10.1 1.15 (0.65, 2.03)
4.3-7.2% 302 10.3 1.17 (0.67, 2.04)
7.3%+ 323 17.0 1.78 (1.05, 3.01)*
Race:
White 1478 11.0 Referent group
Black 86 19.8 2.10 (1.10, 4.02)*
Sex:
Male 803 12.3 Referent group
Female 761 10.5 0.83 (0.58, 1.18)
Stage:
1 1298 12.0 Referent group
11 266 8.6 0.72 (0.44, 1.16)
a The proportion of patients without resection; there is no adjustment for the effects of the
other variables included in the model (see adjusted odds ratio).
bAdjusted odds ratios (ORs) are from a multiple logistic regression model that included all
of the variables shown in the table.
c Selected diseases or conditions (see text).
* P < .05
CL: Confidence limits (95%) (see text)
regression model with non-receipt (vs.
receipt) of surgical resection as the depen-
dent variable, adjusted ORs were statisti-
cally significantly elevated for all six age
categories (vs. the reference category of
less than 55 years), the 5th vs. first quintile
ofSES, 1 vs. 0 and 2+ vs. 0 comorbid con-
ditions, black vs. white race and not mar-Polednak: Disparities in lung cancersurgery 313
ried vs. married, but were close to 1.00 for
sex and stage (Table 1). While ORs are dif-
ficult to interpret in the presence of inter-
actions, there were few statistically signif-
icant interactions (Wald statistic, not
shown); most involved age and SES and
were limited to the oldest age group; in a
separate model (not shown) limited to age
less than 80 years at diagnosis, results
were similar to those shown in Table 1.
DISCUSSION
The finding ofan association between
non-receipt of surgery and black vs. white
race, independent ofthe effect ofthe asso-
ciation between race and SES, supports
the results ofprevious studies using differ-
ent age groups of NSCLC patients [3, 4].
The adjusted OR in Table 1 adjusts for
confounding due to the association
between race and SES, in examining the
association between race and surgical
resection. This finding should be interpret-
ed with caution, however, because of the
small sample of blacks (Table 1) and
"residual confounding" or inadequate con-
trol for SES in comparisons of health-
related outcomes in blacks and whites
[17]. The higher proportion without resec-
tion among unmarried than married
patients, consistent with findings from a
study of elderly NSCLC patients [18],
could reflect residual confounding with
SES and/or a direct role of the spouse in
decision-making, as well as differing per-
ceptions of providers regarding availabili-
ty of post-operative convalescent care for
patients who differ in marital status.
A study limitation is underestimation
of comorbidity from hospital discharge
databases in comparison with medical
record abstraction [10, 11], and the degree
ofunderestimation could vary by age, SES
and/or race. The strong association
between comorbidity and receipt of surgi-
cal resection (Table 1) suggests that mean-
ingful comorbidity was captured.
However, residual confounding with
comorbidity may have occurred in the
analyses of associations between surgery
and other variables such as age, SES and
race. The actual role of specific comorbid
conditions in treatment decisions could
not be determined.
Another study limitation is the use of
an ecologic rather than an individual indi-
cator of SES. However, the ecologic indi-
cator was available for almost all patients,
whereas income of individual patients in
interview studies is often unknown (e.g.,
40 percent of patients in one report) [19].
The unit used in this study was the census
tract, which is the same as that in one pre-
vious study [3] and smaller than the zip
code unit used in another study [4]. Use of
even smaller units such as census block
group was not feasible but would be of
uncertain benefit in estimating the SES of
individual patients [20]. In addition, living
in high-poverty areas may affect health-
care quality and outcomes through mecha-
nisms independent ofthose involving indi-
vidual SES [21].
Studies ofNSCLC are needed in other
geographic areas, and should include larg-
er numbers of patients in high-poverty
areas, more-detailed assessment ofpatient
comorbidity, and both individual and eco-
logic indicators of SES. Both patient pref-
erences and physicians' perceptions of
patients based on patient characteristics
[22, 23] should be explored as possible
explanations for disparities found in this
study.
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